[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP3810274A4 - Combinaison comprenant du fingolimod et au moins un agent anti-épileptique - Google Patents

Combinaison comprenant du fingolimod et au moins un agent anti-épileptique Download PDF

Info

Publication number
EP3810274A4
EP3810274A4 EP19822106.1A EP19822106A EP3810274A4 EP 3810274 A4 EP3810274 A4 EP 3810274A4 EP 19822106 A EP19822106 A EP 19822106A EP 3810274 A4 EP3810274 A4 EP 3810274A4
Authority
EP
European Patent Office
Prior art keywords
fingolimod
combination
epileptic agent
epileptic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19822106.1A
Other languages
German (de)
English (en)
Other versions
EP3810274A2 (fr
Inventor
Ali Turkyilmaz
Merve PEKER
Emine TUNCAY
Erkin Ozturk
Muge ULUSOY BOZYEL
Yavuz Dedeoglu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP3810274A2 publication Critical patent/EP3810274A2/fr
Publication of EP3810274A4 publication Critical patent/EP3810274A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP19822106.1A 2018-06-21 2019-06-19 Combinaison comprenant du fingolimod et au moins un agent anti-épileptique Withdrawn EP3810274A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201808815 2018-06-21
PCT/TR2019/050471 WO2019245512A2 (fr) 2018-06-21 2019-06-19 Combinaison comprenant du fingolimod et au moins un agent anti-épileptique

Publications (2)

Publication Number Publication Date
EP3810274A2 EP3810274A2 (fr) 2021-04-28
EP3810274A4 true EP3810274A4 (fr) 2022-03-16

Family

ID=68983746

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19822106.1A Withdrawn EP3810274A4 (fr) 2018-06-21 2019-06-19 Combinaison comprenant du fingolimod et au moins un agent anti-épileptique

Country Status (2)

Country Link
EP (1) EP3810274A4 (fr)
WO (1) WO2019245512A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010051349A1 (fr) * 2008-10-31 2010-05-06 Lexicon Pharmaceuticals, Inc. Agonistes des récepteurs s1p destinés au traitement du paludisme cérébral
WO2013190151A1 (fr) * 2013-05-13 2013-12-27 Synthon B.V. Composition pharmaceutique contenant du fingolimod

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013022882A1 (fr) * 2011-08-08 2013-02-14 The Board Of Trustees Of The Leland Stanford Junior University Polythérapie pour le traitement de maladie inflammatoire de démyélinisation
US11007192B2 (en) 2016-11-07 2021-05-18 Metriopharm Ag Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple sclerosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010051349A1 (fr) * 2008-10-31 2010-05-06 Lexicon Pharmaceuticals, Inc. Agonistes des récepteurs s1p destinés au traitement du paludisme cérébral
WO2013190151A1 (fr) * 2013-05-13 2013-12-27 Synthon B.V. Composition pharmaceutique contenant du fingolimod

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALICE LARONI ET AL: "Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial", BMC NEUROLOGY, BIOMED CENTRAL LTD., LONDON, GB, vol. 14, no. 1, 1 April 2014 (2014-04-01), pages 65, XP021184467, ISSN: 1471-2377, DOI: 10.1186/1471-2377-14-65 *
See also references of WO2019245512A2 *

Also Published As

Publication number Publication date
WO2019245512A3 (fr) 2020-06-04
WO2019245512A2 (fr) 2019-12-26
EP3810274A2 (fr) 2021-04-28

Similar Documents

Publication Publication Date Title
EP3777445A4 (fr) Numérologie rach dotée d'un fonctionnement bwp
USD741419S1 (en) Exercise band
USD771759S1 (en) Exercise band
EP3723650A4 (fr) Outils médicaux ayant des bandes de tension
EP4041262A4 (fr) Agents de dégradation bifonctionnels ciblés
EP3735608A4 (fr) Dispositif monté sur l'oeil comprenant une femto-caméra et un femto-projecteur
EP3872117A4 (fr) Polyamide souple
EP3265503A4 (fr) Metformine polymère et son utilisation comme agent thérapeutique et comme véhicule d'administration
EP3646730A4 (fr) Miticide et son application
EP3751048A4 (fr) Agent de traitement de fibres
EP3976014A4 (fr) Combinaison comprenant de l'alogliptine et de la metformine
EP3950010A4 (fr) Dispositif de décontamination continue
GB201913756D0 (en) Contrast agent
EP3893866A4 (fr) Combinaison comprenant un agent de sclérose en plaques et au moins un agent anti-épileptique
ZA201906271B (en) Acylnucleoside phosphonates, prodrugs thereof and use thereof as medicament
EP3755678A4 (fr) Formulation d'un biostimulant
EP3769759A4 (fr) Agent de traitement de l'épilepsie
EP3810274A4 (fr) Combinaison comprenant du fingolimod et au moins un agent anti-épileptique
LT3740191T (lt) Oftalmologinės kompozicijos, apimančios bilastiną, beta-ciklodekstriną ir bent vieną gelinimo agentą
GB201801895D0 (en) Medicament packaging assembly
EP4039328A4 (fr) Agent soulageant la dysurie
EP3831399A4 (fr) Agent contre le norovirus
SG11202006539RA (en) Cytocidal agent
EP3810112A4 (fr) Association comprenant du fingolimod et du modafinil
EP3573994A4 (fr) Promédicaments de cystéamine

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201225

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61P0025000000

Ipc: A61K0031137000

A4 Supplementary search report drawn up and despatched

Effective date: 20220216

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/48 20060101ALI20220210BHEP

Ipc: A61K 9/20 20060101ALI20220210BHEP

Ipc: A61K 45/06 20060101ALI20220210BHEP

Ipc: A61P 25/28 20060101ALI20220210BHEP

Ipc: A61K 31/197 20060101ALI20220210BHEP

Ipc: A61K 31/195 20060101ALI20220210BHEP

Ipc: A61K 31/714 20060101ALI20220210BHEP

Ipc: A61P 25/08 20060101ALI20220210BHEP

Ipc: A61P 37/06 20060101ALI20220210BHEP

Ipc: A61P 25/00 20060101ALI20220210BHEP

Ipc: A61K 31/137 20060101AFI20220210BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220920